Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous form
- 31 October 1971
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 14 (2) , 247-258
- https://doi.org/10.1016/0021-9150(71)90054-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatmentJournal of Atherosclerosis Research, 1968
- Cholestyramine therapy in patients homozygous for familial hypercholesterolemia (familial hypercholesterolemic xanthomatosis)Journal of Atherosclerosis Research, 1968
- ILEAL BYPASS IN HYPERCHOLESTEROLÆMIAThe Lancet, 1966
- Determination of free nicotinic acid in blood plasmaClinica Chimica Acta; International Journal of Clinical Chemistry, 1966
- Cholestyramine Resin Therapy for HypercholesteremiaJAMA, 1965
- Studies of Nicotinic Acid Use in HypercholesteremiaArchives of internal medicine (1960), 1961
- Treatment of Hypercholesteremia by Nicotinic AcidArchives of internal medicine (1960), 1961
- Severe Liver Dysfunction During Nicotinic Acid TherapyPublished by American Medical Association (AMA) ,1961
- JAUNDICE OCCURRING DURING NICOTINIC ACID THERAPY FOR HYPERCHOLESTEREMIAJAMA, 1959
- Influence of nicotinic acid on serum cholesterol in manArchives of Biochemistry and Biophysics, 1955